A new review argues that crop wild relatives hold vast untapped genetic diversity, but translating it into better cultivars ...

One of the main ways that the APOE4 gene variant, the biggest genetic risk factor for late-onset Alzheimer's disease, ...

This year, ASHG is pleased to recognize seven recipients of its 2026 Professional Awards for their outstanding achievements in human genetics and genomics research, education, mentorship, and public ...

Researchers combined linkage mapping and association analysis in maize to identify the β-amylase 4 gene Zm00001d039265 and a single SNP that distinguishes high-starch from low-starch kernel lines, ...

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease, is pleased to announce ...

Anyone living with hereditary risk or watching gene-editing headlines needs the moral history those tools still carry. · 0 ...

This report analyzes a large population study investigating links between prenatal depression, antidepressant use, and childhood neurodevelopmental disorders. The findings demonstrate that maternal ...

The world’s most profitable business intelligence (BI) company is strategically shifting its core focus away from the ...

Spread the loveImagine a world where detecting deadly viruses like HIV, influenza, or even the next emergent pathogen isn’t a ...

Recently, the talk show 'A Question of Science,' produced by the Francis Crick Institute in London, released an episode ...

Researchers at Monash University have won more federal funding to keep studying how one of the immune system's brakes works.

Immutep Limited ( IMMP ), a clinical-stage biotechnology company, announced on Wednesday the receipt of a grant from the Australian Research Council (ARC) Linkage Projects scheme, worth AUD 652,248.